Clinical Diagnostics: Global Markets

Report Code: BIO243A

Publish Date: Jul 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

EXPLORE OFFERS

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for clinical diagnostics reached $67.8 billion in 2022. The market is estimated to grow from $73.1 billion in 2023 to reach $103.4 billion by 2028, at a compound annual growth rate (CAGR) of 7.2% from 2023 through 2028.

Report Includes

  • 22 data tables
  • An up-to-date overview and analysis of the global clinical diagnostics market
  • Analyses of the global market trends, with historic market revenue data (sales figures) from 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
  • Discussion of the major growth drivers, opportunities and challenges, technology updates, and the impact of macroeconomic variables influencing the market for clinical diagnostics as a basis for projecting demand in the next few years (2023-2028)
  • Estimation of the actual market size and revenue forecast for global clinical diagnostics market, and corresponding market share analysis based on the type of test, product and service, application, end user, and region
  • In-depth information (facts and figures) concerning the major market dynamics, screening tools and techniques, regulatory developments, new and emerging technologies, and current competitive landscape of the clinical diagnostic market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Bio-Rad Laboratories Inc., Siemens Healthineers, Roche Diagnostics, Qiagen and Thermo Fisher Scientific Inc.

Report Scope

This report aims to provide a comprehensive study of the global market for clinical diagnostics, both quantitative and qualitative data, to help executives develop corporate growth strategies, assess the market landscape, analyze their positions in the current marketplace, and make informed business decisions regarding clinical diagnostics.

An in-depth market analysis includes historical data and market projections on sales by type of test, product type, application, end user and region. It describes the different types of clinical diagnostic tests and their current and historical market revenues. This report also categorizes the global clinical diagnostic market based on four geographic regions: North America, Europe, Asia-Pacific and the Rest of the World (RoW).

For a more in-depth understanding of the market, the report provides profiles of leading companies and their respective market shares.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2023 to 2028
Base year market size $67.8 billion
Market size forecast $103.4 billion
Growth rate CAGR of 7.2% during the forecast period of 2023-2028
Units considered $ Billions
Segments covered By Type of Test, Product Type, Application, End User, and Region
Regions covered North America, Europe, Asia-Pacific, and Rest of the World
Key Market Drivers
  • Advances in Technology
  • Increasing Prevalence of Chronic and Infectious Diseases
  • Autoimmune Disorders
  • Aging Population
  • Rising Healthcare Expenditures
  • Point-of-Care Testing
  • Personalized Medicine
Companies studied
ABBOTTBD
BIOMERIEUXBIO-RAD LABORATORIES INC.
DANAHER CORP.F. HOFFMANN-LA ROCHE LTD.
QIAGENSIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

The clinical diagnostics market is projected to grow from $67.8 million in 2022 to $103.4 billion in 2028, at a compound annual growth rate (CAGR) of 7.2% during the forecast period.
Key drivers of the clinical diagnostics therapeutics market are:
  • Rising prevalence of infectious and chronic diseases.
  • Growing demand for personalized medicine.
  • Advancement in technology.
  • Increasing awareness about early diseases diagnosis.
The clinical diagnostics therapeutics market is segmented on the basis of type of test, product type, application, end-user and region.
Lipid Panel segment will dominate the market by the end of 2028.
North America holds the highest share in the market.
Key companies in the market includes:
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Abbott Laboratories
  • BioMerieux SA
  • F. Hoffmann-La Roche AG
  • Qiagen
  • Siemens Healthineers

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
. Title/Chapter NamePagesPrice Member Price
Full Report: Clinical Diagnostics: Global Markets111 $4,650 Free
Chapter- 1: Introduction10Free DownloadFree
Chapter- 2: Summary and Highlights3$250Free
Chapter- 3: Market and Technology Background11$461Free
Chapter- 4: Clinical Diagnostics Market Breakdown by Type of Test11$461Free
Chapter- 5: Clinical Diagnostics Market Breakdown by Product Type8$335Free
Chapter- 6: Clinical Diagnostics Market Breakdown by Application9$377Free
Chapter- 7: Clinical Diagnostics Market Breakdown by End User5$209Free
Chapter- 8: Clinical Diagnostics Market Breakdown by Region10$419Free
Chapter- 9: Market Dynamics9$377Free
Chapter- 10: Emerging Technologies2$84Free
Chapter- 11: Competitive Landscape2$84Free
Chapter- 12: Company Profiles31$1,299Free

Related Reports

In Vitro Diagnostics (IVD) Analyzers: Global Market

Published - Jan 2024 | Publisher - BCC Publishing | Code - MDS061B

The global market for In Vitro Diagnostics (IVD) analyzers is estimated to increase from $12.9 billion in 2023 to reach $16.3 billion by 2028, at a compound annual growth rate (CAGR) of 4.7% from 2023 through 2028.

Diagnostics and Therapeutics for HIV: Global Markets

Published - Nov 2023 | Publisher - Kottapenta Sai Ratna Bramara Kalyani | Code - PHM058D

The global market for HIV diagnostics and therapeutics is expected to increase from $30.4 billion in 2023 to $39.3 billion by the end of 2028, with compound annual growth rate (CAGR) of 5.3% during the forecast period of 2023-2028.

Molecular Diagnostics: Technologies and Global Markets

Published - May 2022 | Publisher - BCC Publishing | Code - BIO063E

The global molecular diagnostics market should reach $42.6 billion by 2026 from $17.6 billion in 2021 at a compound annual growth rate (CAGR) of 19.3% for the forecast period of 2021 to 2026.

Global Markets for Infectious Disease Treatments

Published - Jan 2022 | Publisher - BCC Publishing | Code - PHM061E

The global market for infectious disease treatments should grow from $72.4 billion in 2021 to $106.3 billion by 2026, at compound annual growth rate (CAGR) of 8.0% for the period of 2021-2026.

Recent Reports

Life Science Tools and Reagents: Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO083E

The global market for life science tools and reagents, including COVID-19 diagnostics was valued at $59.4 billion in 2023. This market is expected to grow from $53.2 billion in 2024 to reach $66.5 billion by the end of 2029, at a CAGR of 4.6% during the forecast period of 2024-2029.

RNAi Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO127C

The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.

Metabolomics: Technologies and Global Markets

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO055E

The global market for metabolomics technologies is expected to grow from $16.4 billion in 2024 and is projected to reach $30.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2024 to 2029.

Global Recombinant Proteins Market

Published - Jul 2024 | Publisher - BCC Publishing | Code - BIO254A

The global market for recombinant proteins is estimated to increase from $132.4 billion in 2023 to reach $203.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.5% from 2024 through 2029.

Polymerase Chain Reaction (PCR) for Point-of-Care (POC) Diagnostics

Published - Jun 2024 | Publisher - Gundreddy Gopinadh | Code - BIO157C

The global market for polymerase chain reaction for point-of-care diagnostics is expected to grow from $1.6 billion in 2024 to $2.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 5.9% from 2024 through 2029.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Clinical Diagnostics: Global Markets
Sample Report